On December 20, 2024, the FDA approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. This makes Zepbound the only drug in history to be approved specifically for OSA — a condition that affects an estimated 30 million Americans and has, until now, been
If you’re considering Zepbound (tirzepatide) for weight loss, you’re probably wondering: when do you see results with Zepbound? Understanding the Zepbound results timeline can help set realistic expectations and keep you motivated throughout your weight loss journey. When Do You See Results with Zepbound? The short answer: most people begin noticing Zepbound first month results,
